UCL Cancer Institute


Myeloma and Plasma Cell Disorders Meeting 2019

30 October 2019, 2:00 pm–6:00 pm

UCL Myeloma and Plasma Cell Disorders Meeting 2019

This annual scientific exchange meeting, organised by the UCLH Centre for Myeloma and Plasma Cell Disorders, provides an opportunity to hear, share and discuss advances in clinical and research activities. Free registration.

Event Information

Open to





UCL Cancer Institute


LT C3.09
UCL Institute of Education
20 Bedford Way


14:00 Welcome - Dr Rakesh Popat (Lecture Theatre C3.09)

Understanding and harnessing immune function

  • Chair: Prof Kwee Yong

14:05 Immunomodulatory targets on the clinical horizon - Dr Kyohei Nakamura, Smyth Lab

14:25 How do insights from animal models advance clinical care in myeloma? - Dr Kim De Veirman, Vanderkerken Lab

14:45 CAR T therapy in myeloma: an update - Dr Lydia Lee

Advances and uncertainties in clinical practice

  • Chair: Dr Jonathan Sive

15:05 Smouldering myeloma: What should we be doing? - Prof Kwee Yong

15:25 COFFEE BREAK (Room C3.11)

Advances and uncertainties in clinical practice (cont.) Chair: Dr Jonathan Sive

15:50 Novel myeloma treatments and clinical trials at UCLH - Dr Rakesh Popat

16:10 NICE appraisals: How to integrate these into the treatment pathway? - Dr Neil Rabin

Plenary lecture

  • Chair: Dr Ashu Wechalekar

16:30 Where do new immunotherapies fit into the myeloma treatment pathway? - Dr Shaji Kumar

Clinical case discussion

  • Chair: Dr Neil Rabin

17:30 Presentation of clinical cases - Dr Jonathan Sive and Dr Chara Kyriakou

18:00 Summary and close - Prof Kwee Yong

18:15 onwards: Drinks reception

Parallel Session for Clinical Nurse Specialists and Trial Practitioners

14:05 - 15:05 - Coordinated and run by Aviva Cerner, UCH Myeloma CNS. (Room C3.13)

  • Nurse-led clinics
  • Best practice Daratumumab infusions
  • Management of treatment toxicities

This meeting is approved for 3 CPD credits by the Royal College of Pathologists.